Metir plc (AIM:MET)
London · Delayed Price · Currency is GBP · Price in GBX 0.7500
-0.0250 (-3.23%)
Jul 10, 2026, 12:17 PM GMT
Metir Revenue
In the year 2025, Metir had annual revenue of 1.44M GBP with 520.69% growth. Metir had revenue of 919.00K in the half year ending June 30, 2025, with 561.15% growth.
Revenue
1.44M
Revenue Growth
+520.69%
P/S Ratio
2.39
Revenue / Employee
288.00K
Employees
4
Market Cap
3.44M
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.44M | 1.21M | 520.69% |
| Dec 31, 2024 | 232.00K | -260.00K | -52.85% |
| Dec 31, 2023 | 492.00K | -1.08M | -68.62% |
| Dec 31, 2022 | 1.57M | 661.12K | 72.90% |
| Dec 31, 2021 | 906.88K | 708.62K | 357.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 45.77B |
| GSK plc | 32.78B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Surgical Innovations Group | 11.60M |
| Cambridge Nutritional Sciences | 8.06M |
| Fortis Frontier | 3.22M |
| Oxford BioDynamics | 1.20M |